These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 19307366
1. Comparative antipneumococcal activities of sulopenem and other drugs. Kosowska-Shick K, Ednie LM, McGhee P, Appelbaum PC. Antimicrob Agents Chemother; 2009 Jun; 53(6):2239-47. PubMed ID: 19307366 [Abstract] [Full Text] [Related]
2. Antipneumococcal activity of ertapenem (MK-0826) compared to those of other agents. Pankuch GA, Davies TA, Jacobs MR, Appelbaum PC. Antimicrob Agents Chemother; 2002 Jan; 46(1):42-6. PubMed ID: 11751109 [Abstract] [Full Text] [Related]
3. Alterations of the penicillin-binding proteins and murM alleles of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin in Spain. Cafini F, del Campo R, Alou L, Sevillano D, Morosini MI, Baquero F, Prieto J, Spanish Pneumococcal Network (G03/103). J Antimicrob Chemother; 2006 Feb; 57(2):224-9. PubMed ID: 16368701 [Abstract] [Full Text] [Related]
4. Antipneumococcal activities of gemifloxacin compared to those of nine other agents. Davies TA, Kelly LM, Pankuch GA, Credito KL, Jacobs MR, Appelbaum PC. Antimicrob Agents Chemother; 2000 Feb; 44(2):304-10. PubMed ID: 10639354 [Abstract] [Full Text] [Related]
5. Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents. Kosowska-Shick K, Credito K, Pankuch GA, Lin G, Bozdogan B, McGhee P, Dewasse B, Choi DR, Ryu JM, Appelbaum PC. Antimicrob Agents Chemother; 2006 Jun; 50(6):2064-71. PubMed ID: 16723567 [Abstract] [Full Text] [Related]
6. MIC and time-kill studies of antipneumococcal activity of GV 118819X (sanfetrinem) compared with those of other agents. Spangler SK, Jacobs MR, Appelbaum PC. Antimicrob Agents Chemother; 1997 Jan; 41(1):148-55. PubMed ID: 8980771 [Abstract] [Full Text] [Related]
7. [Effects of amino acid substitutions of penicillin-binding proteins 2B, 1A, 2X on minimal inhibitory concentration of beta-lactams against Streptococcus pneumoniae]. Xu M, Zhang JH, Ding YF, Tao YZ, Wang ZC. Zhonghua Er Ke Za Zhi; 2010 Jan; 48(1):60-4. PubMed ID: 20441706 [Abstract] [Full Text] [Related]
8. Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococci. Nagai K, Davies TA, Jacobs MR, Appelbaum PC. Antimicrob Agents Chemother; 2002 May; 46(5):1273-80. PubMed ID: 11959556 [Abstract] [Full Text] [Related]
9. Phenotypes and genes of resistance of pneumococci to penicillin isolated from children. Kotevska V, Trajkovska-Dokic E, Jankoska G, Kaftandzieva A, Panovski N, Petrovska M. Prilozi; 2009 Jul; 30(1):143-54. PubMed ID: 19736537 [Abstract] [Full Text] [Related]
10. In vitro selection of resistance to four beta-lactams and azithromycin in Streptococcus pneumoniae. Pankuch GA, Jueneman SA, Davies TA, Jacobs MR, Appelbaum PC. Antimicrob Agents Chemother; 1998 Nov; 42(11):2914-8. PubMed ID: 9797225 [Abstract] [Full Text] [Related]
11. Penicillin-Binding Protein Transpeptidase Signatures for Tracking and Predicting β-Lactam Resistance Levels in Streptococcus pneumoniae. Li Y, Metcalf BJ, Chochua S, Li Z, Gertz RE, Walker H, Hawkins PA, Tran T, Whitney CG, McGee L, Beall BW. mBio; 2016 Jun 14; 7(3):. PubMed ID: 27302760 [Abstract] [Full Text] [Related]
12. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain. Seral C, Suárez L, Rubio-Calvo C, Gómez-Lus R, Gimeno M, Coronel P, Durán E, Becerril R, Oca M, Castillo FJ. Diagn Microbiol Infect Dis; 2008 Oct 14; 62(2):210-5. PubMed ID: 18715733 [Abstract] [Full Text] [Related]
13. Antipneumococcal activity of DK-507k, a new quinolone, compared with the activities of 10 other agents. Browne FA, Bozdogan B, Clark C, Kelly LM, Ednie L, Kosowska K, Dewasse B, Jacobs MR, Appelbaum PC. Antimicrob Agents Chemother; 2003 Dec 14; 47(12):3815-24. PubMed ID: 14638489 [Abstract] [Full Text] [Related]
14. [Evaluation of penicillin-binding protein genotypes in penicillin susceptible and resistant Streptococcus pneumoniae isolates]. Aslan G, Tezcan S, Delialioğlu N, Aydın FE, Kuyucu N, Emekdaş G. Mikrobiyol Bul; 2012 Apr 14; 46(2):190-201. PubMed ID: 22639308 [Abstract] [Full Text] [Related]
15. Activity of ceftobiprole against Streptococcus pneumoniae isolates exhibiting high-level resistance to ceftriaxone. Davies TA, Flamm RK, Lynch AS. Int J Antimicrob Agents; 2012 Jun 14; 39(6):534-8. PubMed ID: 22526015 [Abstract] [Full Text] [Related]
16. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia. Gosbell IB, Fernandes LA, Fernandes CJ. Pathology; 2006 Aug 14; 38(4):343-8. PubMed ID: 16916725 [Abstract] [Full Text] [Related]
17. In vitro susceptibility of 90 penicillin-susceptible and -resistant pneumococci to penicillin G, amoxicillin, amoxicillin/clavulanate, cefaclor, cefuroxime, cefpodoxime, cefixime and imipenem. Hupková H, Trupl J. Folia Microbiol (Praha); 1998 Aug 14; 43(1):68-70. PubMed ID: 9569631 [Abstract] [Full Text] [Related]
18. Penicillin-Binding Protein Typing, Antibiotic Resistance Gene Identification, and Molecular Phylogenetic Analysis of Meropenem-Resistant Streptococcus pneumoniae Serotype 19A-CC3111 Strains in Japan. Nakano S, Fujisawa T, Ito Y, Chang B, Matsumura Y, Yamamoto M, Suga S, Ohnishi M, Nagao M. Antimicrob Agents Chemother; 2019 Sep 14; 63(9):. PubMed ID: 31235623 [Abstract] [Full Text] [Related]
19. Antipneumococcal activity of AZD2563, a new oxazolidinone, compared with nine other agents. Peric M, Lin G, Clark CL, Jacobs MR, Appelbaum PC. J Antimicrob Chemother; 2002 Jul 14; 50(1):95-100. PubMed ID: 12096012 [Abstract] [Full Text] [Related]
20. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents. Peric M, Browne FA, Jacobs MR, Appelbaum PC. Clin Ther; 2003 Jan 14; 25(1):169-77. PubMed ID: 12637118 [Abstract] [Full Text] [Related] Page: [Next] [New Search]